UBS Group’s Vascular Solutions VASC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q1
– Sell
-4,239
Closed -$237K – 8374
2016
Q4
$237K Buy
4,239
+1,401
+49% +$71.4K ﹤0.01% 4676
2016
Q3
$137K Sell
2,838
-993
-26% -$46.3K ﹤0.01% 4796
2016
Q2
$159K Sell
3,831
-3,484
-48% -$130K ﹤0.01% 4700
2016
Q1
$239K Sell
7,315
-2,109
-22% -$60.8K ﹤0.01% 4367
2015
Q4
$324K Sell
9,424
-697
-7% -$23.6K ﹤0.01% 4296
2015
Q3
$328K Buy
10,121
+1,243
+14% +$44.5K ﹤0.01% 4238
2015
Q2
$308K Sell
8,878
-1,866
-17% -$60.9K ﹤0.01% 4498
2015
Q1
$326K Sell
10,744
-4,707
-30% -$135K ﹤0.01% 4486
2014
Q4
$420K Buy
15,451
+2,909
+23% +$79K ﹤0.01% 4349
2014
Q3
$310K Buy
12,542
+741
+6% +$17.6K ﹤0.01% 4742
2014
Q2
$262K Buy
11,801
+1,037
+10% +$22.7K ﹤0.01% 4876
2014
Q1
$282K Buy
10,764
+7,654
+246% +$191K ﹤0.01% 4823
2013
Q4
$72K Buy
3,110
+1,180
+61% +$23.1K ﹤0.01% 6480
2013
Q3
$32K Sell
1,930
-570
-23% -$9.23K ﹤0.01% 7480
2013
Q2
$37K Hold
2,500
– – ﹤0.01% 7143

Other funds holding VASC

UBS Group's VASC Position: Q1 2017 in Review

UBS Group sold out of Vascular Solutions (VASC) in Q1 2017, closing a stake of 4,239 shares — an estimated $237K sold.

UBS Group first reported a position in VASC in Q2 2013 and held it in 15 quarters. The position peaked at $420K in Q4 2014. 1 fund tracked by Wall St. Rank holds VASC as of Q1 2017.

  • UBS Group reported no remaining Vascular Solutions position as of Q1 2017 after selling out during the quarter.
  • UBS Group sold 4,239 Vascular Solutions shares in Q1 2017, an estimated $237K.
  • UBS Group first reported a position in Vascular Solutions in Q2 2013 and held it in 15 quarters.
  • UBS Group's Vascular Solutions position peaked at $420K in Q4 2014.
  • 1 fund tracked by Wall St. Rank held Vascular Solutions as of Q1 2017.

Based on UBS Group's 13F filing for Q1 2017, filed 12 May 2017.